The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(cyclopentylmethyl)-N,N-dimethyl-8-(thiophen-2-yl)-2-azaspiro[4.5]decan-8-amine ID: ALA4454146
PubChem CID: 118662074
Max Phase: Preclinical
Molecular Formula: C21H34N2S
Molecular Weight: 346.58
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CN(C)C1(c2cccs2)CCC2(CCN(CC3CCCC3)C2)CC1
Standard InChI: InChI=1S/C21H34N2S/c1-22(2)21(19-8-5-15-24-19)11-9-20(10-12-21)13-14-23(17-20)16-18-6-3-4-7-18/h5,8,15,18H,3-4,6-7,9-14,16-17H2,1-2H3
Standard InChI Key: GTWAXCUGFVQLLX-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
11.5315 -8.3287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9359 -9.0345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7449 -9.0371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1555 -8.3356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7510 -7.6298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9360 -7.6256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9870 -7.7124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2318 -8.0396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3097 -8.8590 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.1130 -9.0380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7313 -7.7509 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.5222 -7.9564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5138 -6.9632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7313 -8.9107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6971 -9.3998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9224 -9.1396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6045 -9.7145 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
14.3298 -10.0835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9049 -9.5077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5350 -8.7829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6767 -8.3643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8595 -8.3562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5994 -9.1309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2558 -9.6176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
1 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 1 1 0
4 11 1 0
11 12 1 0
11 13 1 0
4 14 1 0
9 15 1 0
15 16 1 0
14 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 14 2 0
16 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 16 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 346.58Molecular Weight (Monoisotopic): 346.2443AlogP: 4.96#Rotatable Bonds: 4Polar Surface Area: 6.48Molecular Species: BASEHBA: 3HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 2HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 10.72CX LogP: 4.76CX LogD: -0.12Aromatic Rings: 1Heavy Atoms: 24QED Weighted: 0.76Np Likeness Score: -0.99
References 1. Rosse G.. (2016) Treatment of Pain with Spirocylic Cyclohexane Derivatives Having Dual Specificity for ORL-1 and μ-Opioid Receptors., 7 (9): [PMID:27660683 ] [10.1021/acsmedchemlett.6b00277 ]